The influence of photodynamic therapy on the immune response

Photodiagnosis and Photodynamic Therapy

Volumn 2, Issue 4, 2005, Pages 283-298

  Nowis, Dominika ^a   Stokłosa, Tomasz ^a   Legat, Magdalena ^a   Issat, Tadeusz ^a   Jakóbisiak, Marek ^a   Goła̧b, Jakub ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Dendritic cells; Immune response; Inflammation; Photodynamic therapy; Tumor

Indexed keywords

3 TETRAHYDROXYPHENYLCHLORIN; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; BACTERIAL VACCINE; BCG VACCINE; BENZOPORPHYRIN DERIVATIVE; CHITOSAN; CORYNEBACTERIUM PARVUM VACCINE; ENDOTOXIN; FAS LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSTIMULATING AGENT; MACROPHAGE ACTIVATING FACTOR; METHOXSALEN; MONOCLONAL ANTIBODY; PHOTOFRIN; PHOTOSENSITIZING AGENT; PICIBANIL; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; RECOMBINANT CYTOKINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 7; RECOMBINANT TUMOR NECROSIS FACTOR; SCHIZOPHYLLAN; SINGLET OXYGEN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; AUTOIMMUNE DISEASE; CANCER CONTROL; CAPILLARY LEAK SYNDROME; COMPLEMENT ACTIVATION; CUTANEOUS T CELL LYMPHOMA; DRUG FATALITY; DRUG POTENTIATION; DRUG TARGETING; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; MACROPHAGE ACTIVATION; MULTIPLE SCLEROSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PAIN; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE ACTIVATION;

BACTERIA (MICROORGANISMS); PROPIONIBACTERIUM ACNES;

EID: 30344485677     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1572-1000(05)00098-0     Document Type: Review

References (145)

1. A.P. Castano, T.N. Demidova, and M.R. Hamblin Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization Photodiagn Photodyn Ther 1 2004 279 293
2. A.P. Castano, T.N. Demidova, and M.R. Hamblin Mechanisms in photodynamic therapy: part two - cellular signaling, cell metabolism and modes of cell death Photodiagn Photodyn Ther 2 2005 1 23
3. A.P. Castano, T.N. Demidova, and M.R. Hamblin Mechanisms in photodynamic therapy: part three - photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction Photodiagn Photodyn Ther 2 2005 91 106
4. D. Nowis, M. Makowski, T. Stoklosa, M. Legat, T. Issat, and J. Golab Direct tumor damage mechanisms of photodynamic therapy Acta Biochim Pol 52 2005 339 352
5. P. Agostinis, E. Buytaert, H. Breyssens, and N. Hendrickx Regulatory pathways in photodynamic therapy induced apoptosis Photochem Photobiol Sci 3 2004 721 729
6. K. Plaetzer, T. Kiesslich, C.B. Oberdanner, and B. Krammer Apoptosis following photodynamic tumor therapy: induction, mechanisms and detection Curr Pharm Des 11 2005 1151 1165
7. V.H. Fingar, S.W. Taber, P.S. Haydon, L.T. Harrison, S.J. Kempf, and T.J. Wieman Vascular damage after photodynamic therapy of solid tumors: a view and comparison of effect in pre-clinical and clinical models at the University of Louisville In Vivo 14 2000 93 100
8. B. Krammer Vascular effects of photodynamic therapy Anticancer Res 21 2001 4271 4277
9. M.J. Gilissen, L.E. van de Merbel-de Wit, W.M. Star, J.F. Koster, and W. Sluiter Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas Cancer Res 53 1993 2548 2552
10. N.C. Riedemann, and P.A. Ward Complement in ischemia reperfusion injury Am J Pathol 162 2003 363 367
11. M. Korbelik, J. Sun, and H. Zeng Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours Br J Cancer 88 2003 760 766
12. A. Curnow, and S.G. Bown The role of reperfusion injury in photodynamic therapy with 5-aminolaevulinic acid - a study on normal rat colon Br J Cancer 86 2002 989 992
13. M. Korbelik, C.S. Parkins, H. Shibuya, I. Cecic, M.R. Stratford, and D.J. Chaplin Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy Br J Cancer 82 2000 1835 1843
14. J. Golab, D. Nowis, and M. Skrzycki Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor J Biol Chem 278 2003 407 414
15. I. Cecic, and M. Korbelik Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors Cancer Lett 183 2002 43 51
16. I. Cecic, C.S. Parkins, and M. Korbelik Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors Photochem Photobiol 74 2001 712 720
17. I. Del Conde, M.A. Cruz, H. Zhang, J.A. Lopez, and V. Afshar-Kharghan Platelet activation leads to activation and propagation of the complement system J Exp Med 201 2005 871 879
18. M. Korbelik, J. Sun, I. Cecic, and K. Serrano Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors Photochem Photobiol Sci 3 2004 812 816
19. J.Y. Matroule, G. Bonizzi, and P. Morliere Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway J Biol Chem 274 1999 2988 3000
20. G. Kick, G. Messer, A. Goetz, G. Plewig, and P. Kind Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding Cancer Res 55 1995 2373 2379
21. D.J. Granville, C.M. Carthy, and H. Jiang Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin Blood 95 2000 256 262
22. M. Korbelik Induction of tumor immunity by photodynamic therapy J Clin Laser Med Surg 14 1996 329 334
23. M. Dellian, C. Abels, G.E. Kuhnle, and A.E. Goetz Effects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumour tissue Br J Cancer 72 1995 1125 1130
24. W.J. de Vree, M.C. Essers, J.F. Koster, and W. Sluiter Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors Cancer Res 57 1997 2555 2558
25. A. Ferrario, and C.J. Gomer Systemic toxicity in mice induced by localized porphyrin photodynamic therapy Cancer Res 50 1990 539 543
26. R.J. Canter, R. Mick, and S.B. Kesmodel Intraperitoneal photodynamic therapy causes a capillary-leak syndrome Ann Surg Oncol 10 2003 514 524
27. S.S. Yom, T.M. Busch, and J.S. Friedberg Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy Photochem Photobiol 78 2003 75 81
28. V.H. Fingar, T.J. Wieman, S.A. Wiehle, and P.B. Cerrito The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion Cancer Res 52 1992 4914 4921
29. J. Sun, I. Cecic, C.S. Parkins, and M. Korbelik Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours Photochem Photobiol Sci 1 2002 690 695
30. S.O. Gollnick, S.S. Evans, and H. Baumann Role of cytokines in photodynamic therapy-induced local and systemic inflammation Br J Cancer 88 2003 1772 1779
31. W. Kobayashi, Q. Liu, and T. Matsumiya Photodynamic therapy upregulates expression of Mac-1 and generation of leukotriene B(4) by human polymorphonuclear leukocytes Oral Oncol 40 2004 506 510
32. F.H. van Duijnhoven, R.I. Aalbers, J.P. Rovers, O.T. Terpstra, and P.J. Kuppen The immunological consequences of photodynamic treatment of cancer, a literature review Immunobiology 207 2003 105 113
33. Q. Peng, and J.M. Nesland Effects of photodynamic therapy on tumor stroma Ultrastruct Pathol 28 2004 333 340
34. M. Korbelik, and I. Cecic Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy Cancer Lett 137 1999 91 98
35. W.J. de Vree, M.C. Essers, H.S. de Bruijn, W.M. Star, J.F. Koster, and W. Sluiter Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo Cancer Res 56 1996 2908 2911
36. H.W. Lim, L. Young, M. Hagan, and I. Gigli Delayed phase of hematoporphyrin-induced phototoxicity: modulation by complement, leukocytes, and antihistamines J Invest Dermatol 84 1985 114 117
37. V.H. Fingar, K.A. Siegel, T.J. Wieman, and K.W. Doak The effects of thromboxane inhibitors on the microvascular and tumor response to photodynamic therapy Photochem Photobiol 58 1993 393 399
38. J. Golab, G. Wilczynski, and R. Zagozdzon Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF Br J Cancer 82 2000 1485 1491
39. G. Krosl, M. Korbelik, J. Krosl, and G.J. Dougherty Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor Cancer Res 56 1996 3281 3286
40. W.J. De Vree, H.S. de Bruijn, G. Kraak-Slee, J.F. Koster, and W. Sluiter The effect of thrombocytopenia on the efficacy of Photofrin-based photodynamic therapy in vivo Proc SPIE-Int Soc Opt Eng 4146 2001 79 85
41. B.W. Henderson, S.O. Gollnick, and J.W. Snyder Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors Cancer Res 64 2004 2120 2126
42. M. Miyasaka, and T. Tanaka Lymphocyte trafficking across high endothelial venules: dogmas and enigmas Nat Rev Immunol 4 2004 360 370
43. I. Reiter, G. Schwamberger, and B. Krammer Effect of photodynamic pretreatment on the susceptibility of murine tumor cells to macrophage antitumor mechanisms Photochem Photobiol 66 1997 384 388
44. S. Evans, W. Matthews, R. Perry, D. Fraker, J. Norton, and H.I. Pass Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages J Natl Cancer Inst 82 1990 34 39
45. N. Yamamoto, S. Homma, T.W. Sery, L.A. Donoso, and J.K. Hoober Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light Eur J Cancer 27 1991 467 471
46. N. Yamamoto, J.K. Hoober, N. Yamamoto, and S. Yamamoto Tumoricidal capacities of macrophages photodynamically activated with hematoporphyrin derivative Photochem Photobiol 56 1992 245 250
47. S. Coutier, L. Bezdetnaya, and S. Marchal Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity Br J Cancer 81 1999 37 42
48. G. Krosl, M. Korbelik, and G.J. Dougherty Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy Br J Cancer 71 1995 549 555
49. I. Reiter, G. Schwamberger, and B. Krammer Activation of macrophage tumoricidal activity by photodynamic treatment in vitro - indirect activation of macrophages by photodynamically killed tumor cells J Photochem Photobiol B 50 1999 99 107
50. M.H. Deininger, T. Weinschenk, M.H. Morgalla, R. Meyermann, and H.J. Schluesener Release of regulators of angiogenesis following Hypocrellin-A and -B photodynamic therapy of human brain tumor cells Biochem Biophys Res Commun 298 2002 520 530
51. M. Korbelik, and G. Krosl Enhanced macrophage cytotoxicity against tumor cells treated with photodynamic therapy Photochem Photobiol 60 1994 497 502
52. R. Zagozdzon, J. Golab, and T. Stoklosa Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin Int J Cancer 77 1998 720 727
53. M. Korbelik, V.R. Naraparaju, and N. Yamamoto Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer Br J Cancer 75 1997 202 207
54. M. Korbelik, and I. Cecic Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment J Photochem Photobiol B 44 1998 151 158
55. L. Yang, and D.P. Carbone Tumor-host immune interactions and dendritic cell dysfunction Adv Cancer Res 92 2004 13 27
56. J. Banchereau, and A.K. Palucka Dendritic cells as therapeutic vaccines against cancer Nat Rev Immunol 5 2005 296 306
57. D. Pardoll Does the immune system see tumors as foreign or self? Annu Rev Immunol 21 2003 807 839
58. E.J. Fuchs, and P. Matzinger Is cancer dangerous to the immune system? Semin Immunol 8 1996 271 280
59. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena Antigen presentation and T cell stimulation by dendritic cells Annu Rev Immunol 20 2002 621 667
60. D.W. O'Neill, S. Adams, and N. Bhardwaj Manipulating dendritic cell biology for the active immunotherapy of cancer Blood 104 2004 2235 2246
61. A.D. Wells, and M. Malkovsky Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view Immunol Today 21 2000 129 132
62. G.P. Dunn, L.J. Old, and R.D. Schreiber The three Es of cancer immunoediting Annu Rev Immunol 22 2004 329 360
63. A. Mazzoni, and D.M. Segal Controlling the Toll road to dendritic cell polarization J Leukoc Biol 75 2004 721 730
64. F. Cottrez, and H. Groux Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells Transplantation 77 2004 S12 S15
65. M. Jakobisiak, W. Lasek, and J. Golab Natural mechanisms protecting against cancer Immunol Lett 90 2003 103 122
66. M.J. Smyth, E. Cretney, M.H. Kershaw, and Y. Hayakawa Cytokines in cancer immunity and immunotherapy Immunol Rev 202 2004 275 293
67. P. Frandji, C. Tkaczyk, C. Oskeritzian, B. David, C. Desaymard, and S. Mecheri Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes Eur J Immunol 26 1996 2517 2528
68. A. Stoppacciaro, C. Melani, and M. Parenza Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma J Exp Med 178 1993 151 161
69. M. Skoberne, A.S. Beignon, M. Larsson, and N. Bhardwaj Apoptotic cells at the crossroads of tolerance and immunity Curr Top Microbiol Immunol 289 2005 259 292
70. A.E. Morelli, and A.W. Thomson Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction Immunol Rev 196 2003 125 146
71. W. van Eden, R. van der Zee, and B. Prakken Heat-shock proteins induce T-cell regulation of chronic inflammation Nat Rev Immunol 5 2005 318 330
72. C.V. Nicchitta Re-evaluating the role of heat-shock protein-peptide interactions in tumour immunity Nat Rev Immunol 3 2003 427 432
73. M.K. Chang, C.J. Binder, and Y.I. Miller Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory J Exp Med 200 2004 1359 1370
74. S.J. Prasad, K.J. Farrand, S.A. Matthews, J.H. Chang, R.S. McHugh, and F. Ronchese Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T cells J Immunol 174 2005 90 98
75. A. Jalili, M. Makowski, and T. Switaj Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells Clin Cancer Res 10 2004 4498 4508
76. S.O. Gollnick, L. Vaughan, and B.W. Henderson Generation of effective antitumor vaccines using photodynamic therapy Cancer Res 62 2002 1604 1608
77. M. Korbelik, J. Sun, and I. Cecic Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response Cancer Res 65 2005 1018 1026
78. J.A. Hendrzak-Henion, T.L. Knisely, L. Cincotta, E. Cincotta, and A.H. Cincotta Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy Photochem Photobiol 69 1999 575 581
79. M. Korbelik, and G.J. Dougherty Photodynamic therapy-mediated immune response against subcutaneous mouse tumors Cancer Res 59 1999 1941 1946
80. G. Canti, D. Lattuada, A. Nicolin, P. Taroni, G. Valentini, and R. Cubeddu Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light Anticancer Drugs 5 1994 443 447
81. E.S. Abdel-Hady, P. Martin-Hirsch, and M. Duggan-Keen Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy Cancer Res 61 2001 192 196
82. D.J. Blom, H.J. Schuitmaker, I. de Waard-Siebinga, T.M. Dubbelman, and M.J. Jager Decreased expression of HLA class I on ocular melanoma cells following in vitro photodynamic therapy Cancer Lett 112 1997 239 243
83. F.H. van Duijnhoven, R.I. Aalbers, J.P. Rovers, O.T. Terpstra, and P.J. Kuppen Immunological aspects of photodynamic therapy of liver tumors in a rat model for colorectal cancer Photochem Photobiol 78 2003 235 240
84. T. Momma, M.R. Hamblin, H.C. Wu, and T. Hasan Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis Cancer Res 58 1998 5425 5431
85. W.R. Chen, M. Korbelik, K.E. Bartels, H. Liu, J. Sun, and R.E. Nordquist Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant Photochem Photobiol 81 2005 190 195
86. G. Krosl, and M. Korbelik Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG) Cancer Lett 84 1994 43 49
87. M. Uehara, K. Sano, Z.L. Wang, J. Sekine, H. Ikeda, and T. Inokuchi Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma Cancer Immunol Immunother 49 2000 401 409
88. R.C. Myers, B.H. Lau, D.Y. Kunihira, R.R. Torrey, J.L. Woolley, and J. Tosk Modulation of hematoporphyrin derivative-sensitized phototherapy with Corynebacterium parvum in murine transitional cell carcinoma Urology 33 1989 230 235
89. D.J. Granville, H. Jiang, B.M. McManus, and D.W. Hunt Fas ligand and TRAIL augment the effect of photodynamic therapy on the induction of apoptosis in JURKAT cells Int Immunopharmacol 1 2001 1831 1840
90. D.A. Bellnier Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha J Photochem Photobiol B 8 1991 203 210
91. T. Switaj, A. Jalili, and A.B. Jakubowska CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice Clin Cancer Res 10 2004 4165 4175
92. K. Kozar, R. Kaminski, and T. Switaj Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2′-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice Clin Cancer Res 9 2003 3124 3133
93. J. Golab, and R. Zagozdzon Antitumor effects of interleukin-12 in pre-clinical and early clinical studies (Review) Int J Mol Med 3 1999 537 544
94. J. Usuda, T. Okunaka, and K. Furukawa Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis Int J Cancer 93 2001 475 480
95. W. Liu, A.R. Oseroff, and H. Baumann Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells Cancer Res 64 2004 6579 6587
96. S.H. Jee, S.C. Shen, H.C. Chiu, W.L. Tsai, and M.L. Kuo Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency Oncogene 20 2001 198 208
97. J.K. Steele, D. Liu, A.T. Stammers, S. Whitney, and J.G. Levy Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells Cancer Immunol Immunother 26 1988 125 131
98. M. Korbelik, and J. Sun Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line Int J Cancer 93 2001 269 274
99. R. Schneider, F. Schmitt, and C. Frochot Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy Bioorg Med Chem 13 2005 2799 2808
100. R.Z. Renno, Y. Terada, M.J. Haddadin, N.A. Michaud, E.S. Gragoudas, and J.W. Miller Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2 Arch Ophthalmol 122 2004 1002 1011
101. D. Mew, C.K. Wat, G.H. Towers, and J.G. Levy Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody- hematoporphyrin conjugates J Immunol 130 1983 1473 1477
102. G.A. van Dongen, G.W. Visser, and M.B. Vrouenraets Photosensitizer- antibody conjugates for detection and therapy of cancer Adv Drug Deliv Rev 56 2004 31 52
103. M.B. Vrouenraets, G.W. Visser, and F.A. Stewart Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy Cancer Res 59 1999 1505 1513
104. M.B. Vrouenraets, G.W. Visser, M. Stigter, H. Oppelaar, G.B. Snow, and G.A. van Dongen Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy Cancer Res 61 2001 1970 1975
105. C.A. Elmets, and K.D. Bowen Immunological suppression in mice treated with hematoporphyrin derivative photoradiation Cancer Res 46 1986 1608 1611
106. G.O. Simkin, D.E. King, J.G. Levy, A.H. Chan, and D.W. Hunt Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative Immunopharmacology 37 1997 221 230
107. D.A. Musser, and R.J. Fiel Cutaneous photosensitizing and immunosuppressive effects of a series of tumor localizing porphyrins Photochem Photobiol 53 1991 119 123
108. S. Radakovic-Fijan, U. Blecha-Thalhammer, and V. Schleyer Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study Br J Dermatol 152 2005 279 283
109. B. Qin, S.H. Selman, K.M. Payne, R.W. Keck, and D.W. Metzger Enhanced skin allograft survival after photodynamic therapy. Association with lymphocyte inactivation and macrophage stimulation Transplantation 56 1993 1481 1486
110. C.J. Jolles, M.J. Ott, R.C. Straight, and D.H. Lynch Systemic immunosuppression induced by peritoneal photodynamic therapy Am J Obstet Gynecol 158 1988 1446 1453
111. D.H. Lynch, S. Haddad, V.J. King, M.J. Ott, R.C. Straight, and C.J. Jolles Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages Photochem Photobiol 49 1989 453 458
112. E.A. Hryhorenko, A.R. Oseroff, J. Morgan, and K. Rittenhouse-Diakun Antigen specific and nonspecific modulation of the immune response by aminolevulinic acid based photodynamic therapy Immunopharmacology 40 1998 231 240
113. D.W. Hunt, H. Jiang, D.J. Granville, A.H. Chan, S. Leong, and J.G. Levy Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes Immunopharmacology 41 1999 31 44
114. S. Gruner, H.D. Volk, F. Noack, H. Meffert, and R. von Baehr Inhibition of HLA-DR antigen expression and of the allogeneic mixed leukocyte reaction by photochemical treatment Tissue Antigens 27 1986 147 154
115. S. Gruner, H. Meffert, H.D. Volk, R. Grunow, and S. Jahn The influence of haematoporphyrin derivative and visible light on murine skin graft survival, epidermal Langerhans cells and stimulation of the allogeneic mixed leucocyte reaction Scand J Immunol 21 1985 267 273
116. D.E. King, H. Jiang, G.O. Simkin, M.O. Obochi, J.G. Levy, and D.W. Hunt Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells Scand J Immunol 49 1999 184 192
117. M. Korbelik, J. Sun, and J.J. Posakony Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors Photochem Photobiol 73 2001 403 409
118. J. Krutmann, M. Athar, and D.B. Mendel Inhibition of the high affinity Fc receptor (Fc gamma RI) on human monocytes by porphyrin photosensitization is highly specific and mediated by the generation of superoxide radicals J Biol Chem 264 1989 11407 11413
119. D.W. Hunt, H.J. Jiang, J.G. Levy, and A.H. Chan Sensitivity of activated murine peritoneal macrophages to photodynamic killing with benzoporphyrin derivative Photochem Photobiol 61 1995 417 421
120. D.A. Musser, S.H. Camacho, P.A. Manderscheid, and A.R. Oseroff The anatomic site of photodynamic therapy is a determinant for immunosuppression in a murine model Photochem Photobiol 69 1999 222 225
121. S.O. Gollnick, X. Liu, B. Owczarczak, D.A. Musser, and B.W. Henderson Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo Cancer Res 57 1997 3904 3909
122. A.P. Vicari, and G. Trinchieri Interleukin-10 in viral diseases and cancer: exiting the labyrinth? Immunol Rev 202 2004 223 236
123. G.O. Simkin, J.S. Tao, J.G. Levy, and D.W. Hunt IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy J Immunol 164 2000 2457 2462
124. S.O. Gollnick, B.Y. Lee, L. Vaughan, B. Owczarczak, and B.W. Henderson Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytes Photochem Photobiol 73 2001 170 177
125. S.O. Gollnick, D.A. Musser, A.R. Oseroff, L. Vaughan, B. Owczarczak, and B.W. Henderson IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response Photochem Photobiol 74 2001 811 816
126. R.K. Chowdhary, L.G. Ratkay, and H.C. Neyndorff The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice Clin Immunol Immunopathol 72 1994 255 263
127. K.B. Trauner, R. Gandour-Edwards, M. Bamberg, S. Shortkroff, C. Sledge, and T. Hasan Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis Photochem Photobiol 67 1998 133 139
128. S. Leong, A.H. Chan, J.G. Levy, and D.W. Hunt Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis Photochem Photobiol 64 1996 751 757
129. G. Cavaletti, P. Perseghin, and M. Dassi Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells J Biol Regul Homeost Agents 18 2004 9 17
130. D.P. Besnier, D. Chabannes, J.M. Mussini, B. Dupas, and V.L. Esnault Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study Photodermatol Photoimmunol Photomed 18 2002 36 41
131. R. Bissonnette, J.F. Tremblay, P. Juzenas, M. Boushira, and H. Lui Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques J Invest Dermatol 119 2002 77 83
132. W.H. Boehncke, K. Konig, R. Kaufmann, W. Scheffold, O. Prummer, and W. Sterry Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo Arch Dermatol Res 286 1994 300 303
133. J. Svennilson Novel approaches in GVHD therapy Bone Marrow Transplant 35 Suppl. 1 2005 S65 S67
134. D.W. Edstrom, A. Porwit, and A.M. Ros Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response Acta Derm Venereol 81 2001 184 188
135. T.N. Demidova, and M.R. Hamblin Macrophage-targeted photodynamic therapy Int J Immunopathol Pharmacol 17 2004 117 126
136. H.T. Greinix, B. Volc-Platzer, and P. Kalhs Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study Blood 96 2000 2426 2431
137. J. Kanold, C. Messina, and P. Halle Update on extracorporeal photochemotherapy for graft-versus-host disease treatment Bone Marrow Transplant 35 Suppl. 1 2005 S69 S71
138. B.J. Chen, X. Cui, C. Liu, and N.J. Chao Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process Blood 99 2002 3083 3088
139. E.F. Gudgin Dickson, R.L. Goyan, and R.H. Pottier New directions in photodynamic therapy Cell Mol Biol (Noisy-le-grand) 48 2002 939 954
140. C.M. Mulroney, S. Gluck, and A.D. Ho The use of photodynamic therapy in bone marrow purging Semin Oncol 21 1994 24 27
141. L. Villeneuve Ex vivo photodynamic purging in chronic myelogenous leukaemia and other neoplasias with rhodamine derivatives Biotechnol Appl Biochem 30 Pt 1 1999 1 17
142. N. Brasseur, I. Menard, and A. Forget Eradication of multiple myeloma and breast cancer cells by TH9402-mediated photodynamic therapy: implication for clinical ex vivo purging of autologous stem cell transplants Photochem Photobiol 72 2000 780 787
143. G.S. Anderson, I. Tsujino, K. Miyagi, R. Sampson, and F. Sieber Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic stem cell grafts J Photochem Photobiol B 69 2003 87 95
144. B.W. Henderson, S.M. Waldow, T.S. Mang, W.R. Potter, P.B. Malone, and T.J. Dougherty Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy Cancer Res 45 1985 572 576
145. W.S. Chan, N. Brasseur, C. La Madeleine, and J.E. van Lier Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow Anticancer Res 16 1996 1887 1892